Education
About Us
Working with TipRanks
Follow Us
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
Total Valuation
OptimizeRx has a market cap or net worth of $187.71M. The enterprise value is $162.13M.
Market Cap$187.71M
Enterprise Value$162.13M
Share Statistics
OptimizeRx has 18,640,652 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,640,652
Owned by Insiders9.71%
Owned by Institutions35.13%
Financial Efficiency
OptimizeRx’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -8.86%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-8.86%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee719.74K
Profits Per Employee-157.11K
Employee Count128
Asset Turnover0.54
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OptimizeRx is ―. OptimizeRx’s PEG ratio is -0.65.
PE Ratio―
PS Ratio0.97
PB Ratio0.76
Price to Fair Value0.76
Price to FCF18.61
Price to Operating Cash Flow12.86
PEG Ratio-0.65
Income Statement
In the last 12 months, OptimizeRx had revenue of 92.13M and earned -20.11M in profits. Earnings per share was -1.10.
Revenue92.13M
Gross Profit59.38M
Operating Income-13.71M
Pretax Income-19.39M
Net Income-20.11M
EBITDA-8.90M
Earnings Per Share (EPS)-1.10
Cash Flow
In the last 12 months, operating cash flow was 11.82M and capital expenditures -167.00K, giving a free cash flow of 11.66M billion.
Operating Cash Flow11.82M
Free Cash Flow11.66M
Free Cash Flow per Share0.63
Dividends & Yields
OptimizeRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.02
52-Week Price Change39.01%
50-Day Moving Average12.51
200-Day Moving Average14.61
Relative Strength Index (RSI)29.49
Average Volume (3m)275.17K
Important Dates
OptimizeRx upcoming earnings date is Mar 5, 2026, TBA (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 5, 2026
Ex-Dividend Date―
Financial Position
OptimizeRx as a current ratio of 2.89, with Debt / Equity ratio of 23.40%
Current Ratio2.89
Quick Ratio2.89
Debt to Market Cap0.37
Net Debt to EBITDA-2.23
Interest Coverage Ratio-2.23
Taxes
In the past 12 months, OptimizeRx has paid 725.00K in taxes.
Income Tax725.00K
Effective Tax Rate-0.04
Enterprise Valuation
OptimizeRx EV to EBITDA ratio is -12.22, with an EV/FCF ratio of 22.76.
EV to Sales1.18
EV to EBITDA-12.22
EV to Free Cash Flow22.76
EV to Operating Cash Flow22.24
Balance Sheet
OptimizeRx has $19.52M in cash and marketable securities with $28.61M in debt, giving a net cash position of -$9.09M billion.
Cash & Marketable Securities$19.52M
Total Debt$28.61M
Net Cash-$9.09M
Net Cash Per Share-$0.49
Tangible Book Value Per Share$0.03
Margins
Gross margin is 65.31%, with operating margin of -14.88%, and net profit margin of -21.83%.
Gross Margin65.31%
Operating Margin-14.88%
Pretax Margin-21.04%
Net Profit Margin-21.83%
EBITDA Margin-9.66%
EBIT Margin-14.36%
Analyst Forecast
The average price target for OptimizeRx is $20.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$20.67
Price Target Upside99.71% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast24.19%
EPS Growth Forecast―